Dr. Christopher R. Friese is a national authority in measuring and improving the quality of cancer care delivery. Over his career,  he has led pivotal studies to develop and test strategies to improve outcomes of high-risk care.  His research findings were among the first to establish a significant relationship between favorable nurse practice environments and lower surgical mortality. With over 100 peer-reviewed publications, Dr. Friese’s research findings have informed clinical practice guidelines, and state and federal health policy. Dr. Friese spent 2016-2017 as a Robert Wood Johnson Foundation Health Policy Fellow in the United States Senate. A clinical expert in hematological malignancies and advanced cancers, Dr. Friese continues to practice as a staff nurse at the University of Michigan Rogel Cancer Center. In 2021, the President appointed Dr. Friese to a six-year term on the National Cancer Advisory Board, which sets national cancer research policy. In 2021, the President appointed Dr. Friese to a six-year term on the National Cancer Advisory Board, which sets national cancer research policy.